Sutent 12.5 mg hard capsules Thailand - English - myHealthbox

sutent 12.5 mg hard capsules

pfizer - sunitinib - hard gelatin capsules - 12.5 mg - antineoplastic agents - sunitinib is indicated for the treatment of gastrointestinal stromal tumor (gist) after failure of imatinib mesylate treatment due to resistance or intolerance. sunitinib is indicated for the treatment of advanced and/or metastatic renal cell carcinoma (mrcc). sunitinib is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumors (pnet) with disease progression.

Sunitinib AqVida Capsules Hard 25mg Malta - English - Medicines Authority

sunitinib aqvida capsules hard 25mg

aqvida gmbh kaiser-wilhelm-str 89, 20355 hamburg, germany - sunitinib - hard capsule - sunitinib 25 mg - antineoplastic agents

Sunitinib AqVida Capsules Hard 37.5mg Malta - English - Medicines Authority

sunitinib aqvida capsules hard 37.5mg

aqvida gmbh kaiser-wilhelm-str 89, 20355 hamburg, germany - sunitinib - hard capsule - sunitinib 37.5 mg - antineoplastic agents

Sunitinib AqVida Capsules Hard 50mg Malta - English - Medicines Authority

sunitinib aqvida capsules hard 50mg

aqvida gmbh kaiser-wilhelm-str 89, 20355 hamburg, germany - sunitinib - hard capsule - sunitinib 50 mg - antineoplastic agents

Sunitinib AqVida Capsules Hard 12.5mg Malta - English - Medicines Authority

sunitinib aqvida capsules hard 12.5mg

aqvida gmbh kaiser-wilhelm-str 89, 20355 hamburg, germany - sunitinib - hard capsule - sunitinib 12.5 mg - antineoplastic agents

Maxinib 12.5mg Hard Capsules Malta - English - Medicines Authority

maxinib 12.5mg hard capsules

boston biopharma limited malta life sciences park, building 2, level 0, san gwann sgn 3000, malta - sunitinib - hard capsule - sunitinib 12.5 mg - antineoplastic agents

Maxinib 25mg Hard Capsules Malta - English - Medicines Authority

maxinib 25mg hard capsules

boston biopharma limited malta life sciences park, building 2, level 0, san gwann sgn 3000, malta - sunitinib - hard capsule - sunitinib 25 mg - antineoplastic agents